Page 34 - க்ளேண்மர்க் வாழ்க்கை அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Glenmark arm files IPO papers with SEBI April 17, 2021 Plans to sell over 73 lakh shares via Offer For Sale Glenmark Life Sciences Limited, a wholly-owned subsidiary of Glenmark Pharmaceuticals Limited, has filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer. The company plans to raise ₹1,160 crore with an Offer For Sale of up to 7,305,245 equity shares of ₹2 each of Glenmark Life Sciences Limited. The board of directors of Glenmark Pharmaceuticals Limitedon Friday approved the OFS. Glenmark Pharma holds 100 per cent stake in Glenmark Life Sciences, which is primarily into manufacturing and marketing of Active Pharmaceutical Ingredients (APIs). It has a product portfolio of more than 130 APIs and a catalogue of over 270 inventions. The firm, which supplies APIs to more than 700 customers across 65 countries, also develops 10-12 new products every year. Glenmark Life Sciences has manufacturing operations in Gujara

Glenmark pharmaGlenmark life sciencesGlenmark pharmaceuticals limitedonExchange board of indiaGlenmark pharmaceuticalsGlenmark life sciences limitedGlenmark pharmaceuticals limitedExchange boardOffer for saleGlenmark pharmaceuticals limitedon fridayActive pharmaceutical ingredientsLife sciencesக்ளேண்மர்க் பார்மாக்ளேண்மர்க் வாழ்க்கை அறிவியல்பரிமாற்றம் பலகை ஆஃப் இந்தியாக்ளேண்மர்க் மருந்துகள்